EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways

Chen, Xiangliu; Huang, Yingying; Liu, Jin; Lin, Wu; Chen, Chuanzhi; Chen, Yiran; Ding, Yongfeng; Yang, Yan; Chen, Yanyan; Wang, Haiyong; Teng, Lisong

doi:10.7150/jca.69166



International Journal of Biological Sciences

International Journal of Medical Sciences

Theranostics

Journal of Genomics

Nanotheranostics

Global reach, higher impact

Full Text | PDF

J Cancer 2022; 13(5):1456-1467. doi:10.7150/jca.69166 This issue Cite

Research Paper

EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways

Xiangliu Chen, Yingying Huang, Jin Liu, Wu Lin, Chuanzhi Chen, Yiran Chen, Yongfeng Ding, Yan Yang, Yanyan Chen, Haiyong Wang^✉, Lisong Teng^✉

Department of Surgical Oncology, The First Affiliated Hospital, School of Medicine, Zhejiang University.

Citation:

Chen X, Huang Y, Liu J, Lin W, Chen C, Chen Y, Ding Y, Yang Y, Chen Y, Wang H, Teng L. EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways. J Cancer 2022; 13(5):1456-1467. doi:10.7150/jca.69166. https://www.jcancer.org/v13p1456.htm

Other styles

Abstract

Purpose: Exosome component 5 (EXOSC5) is a non-catalytic component of the RNA exosome complex, which is interacted with the Zinc-finger antiviral protein to degrade the target RNA and aberrantly expressed in various malignances. We explored the molecular mechanisms and biological roles by which EXOSC5 promotes the progression of GC.

Methods: We used quantitative real-time PCR, Western blotting and immunohistochemistry to analyze EXOSC5 expression in GC samples. An GC organoid-based functional model was assessed, and cancer cell CCK-8 assay, colony formation assay and flow cytometry were performed to reveal the role of EXOSC5 in GC cell proliferation and tumorigenesis. In vivo, nude mice tumorigenesis assay were performed to explore the effects of EXOSC5 knockdown on growth of GC. The roles of EXOSC5 on AKT and STAT3 signaling pathways were measured by Western blot.

Results: The expression of EXOSC5 was up-regulated in GC tissues and cell lines compared with normal group, and highly expressed EXOSC5 indicated a poorer clinical outcome for GC patients and was positively correlated with tumor size and TNM stage. EXOSC5 overexpression facilitated the growth of GC cells and organoids, while EXOSC5 downregulation inhibited proliferation and induced G1/S phase transition arrest. Moreover, mechanistic studies demonstrated that EXOSC5 increased cyclinD1 expression levels and decreasing the expression levels of p21 and p27 via regulation of the AKT and STAT3 pathway.

Conclusion: The expression of EXOSC5 is upregulated and correlated with tumorigenesis and poor prognosis of GC. EXOSC5 increases GC proliferation partly through activating AKT and STAT3 pathways.

Keywords: EXOSC5, gastric cancer, proliferation, AKT, STAT3, Prognosis

Citation styles

APA

Chen, X., Huang, Y., Liu, J., Lin, W., Chen, C., Chen, Y., Ding, Y., Yang, Y., Chen, Y., Wang, H., Teng, L. (2022). EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways. Journal of Cancer, 13(5), 1456-1467. https://doi.org/10.7150/jca.69166.

ACS

Chen, X.; Huang, Y.; Liu, J.; Lin, W.; Chen, C.; Chen, Y.; Ding, Y.; Yang, Y.; Chen, Y.; Wang, H.; Teng, L. EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways. J. Cancer 2022, 13 (5), 1456-1467. DOI: 10.7150/jca.69166.

NLM

CSE

Chen X, Huang Y, Liu J, Lin W, Chen C, Chen Y, Ding Y, Yang Y, Chen Y, Wang H, Teng L. 2022. EXOSC5 promotes proliferation of gastric cancer through regulating AKT/STAT3 signaling pathways. J Cancer. 13(5):1456-1467.

This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/). See http://ivyspring.com/terms for full terms and conditions.